Karen Pendergrass

Karen Pendergrass, Standards Team

About

Karen Pendergrass is a microbiome researcher specializing in microbiome-targeted interventions (MBTIs). She systematically analyzes scientific literature to identify microbial patterns, develop hypotheses, and validate interventions. As the founder of the Microbiome Signatures Database, she bridges microbiome research with clinical practice. In 2012, based on her own investigative research, she became the first documented case of FMT for Celiac Disease, four years before the first published case study.

Recent Posts

2025-11-28

Metal Homeostasis

Transition metals like iron, zinc, copper, and manganese are crucial for the enzymatic machinery of organisms, but their imbalance can foster pathogenic environments within the gastrointestinal tract.

2025-11-28

Nickel

Bacteria regulate transition metal levels through complex mechanisms to ensure survival and adaptability, influencing both their physiology and the development of antimicrobial strategies.

2025-11-27

Role of Nickel in Microbial Pathogenesis

Nickel-dependent enzymes like urease and hydrogenase are essential for pathogen virulence. This review outlines the mechanisms by which pathogens acquire and utilize nickel and explores implications for therapy and microbiome balance.

2025-11-27

Compositional changes in fecal microbiota associated with clinical phenotypes and prognosis in Korean patients with inflammatory bowel disease

What was studied? The study examined fecal microbiota in IBD to determine how microbial composition differs between Korean patients with ulcerative colitis (UC), Crohn’s disease (CD), and healthy controls, and whether specific taxa function as biomarkers for disease severity, extent, and prognosis ir-2021-00168. Researchers used 16S rRNA gene sequencing of stool samples to characterize microbial […]

2025-11-24

Polycystic ovary syndrome (PCOS)

Polycystic ovary syndrome (PCOS) is a common endocrine disorder that affects women of reproductive age, characterized by irregular menstrual cycles, hyperandrogenism, and insulin resistance. It is often associated with metabolic dysfunctions and inflammation, leading to fertility issues and increased risk of type 2 diabetes and cardiovascular disease.

2025-11-24

E. coli Nissle 1917

Escherichia coli Nissle 1917 (EcN) is a rare, non-pathogenic strain of E. coli discovered during World War I from a soldier who did not get dysentery while others did. Unlike harmful E. coli, EcN acts as a probiotic: it settles in the gut, competes with bad bacteria for food and space, produces natural antimicrobials, and even helps strengthen the gut barrier.

2025-11-18

Pathogens Outcompeted by E. coli Nissle 1917 and Beneficial Conditions

Escherichia coli Nissle 1917 (EcN) is a highly regarded probiotic strain with significant clinical value due to its ability to outcompete a wide range of pathogenic microorganisms in the gastrointestinal tract. Through the formation of robust biofilms on intestinal epithelial surfaces, EcN effectively blocks the adhesion and colonization of pathogens such as Salmonella, Shigella, and Klebsiella pneumoniae.

2025-11-16

β-Glucuronidase

β-glucuronidase in the gut microbiome breaks down metabolites, drugs, and hormone conjugates like estrogen, aiding microbial energy use and nutrient cycling. Its activity influences drug efficacy and hormone levels, maintaining estrogen balance and impacting health. Disruption in this process can lead to estrogen-related diseases, such as gynecological cancers and menopausal syndrome, and increase colorectal cancer risks by reactivating carcinogens, highlighting its pivotal role in linking microbial actions to host physiological processes.

2025-11-15

Microsporum canis (M. canis)

OverviewMicrosporum canis (M. canis) is a zoophilic dermatophyte common in cats and dogs, responsible for 90% of feline dermatophytoses worldwide.[1][2] It has significant zoonotic potential, transmitting to humans through fomites or direct animal contact, causing severe superficial mycosis. M. canis is considered anthropo-zoophilic and can infect pediatric or immunocompromised patients, causing severe inflammatory responses such […]

2025-11-15

Zinc Oxide Nanoparticles Suppress Microsporum canis Growth and Virulence

Zinc oxide nanoparticles inhibited Microsporum canis growth in a concentration-dependent manner and significantly reduced SUB1 virulence-gene expression. MIC values of 250–500 ppm and fungicidal activity at 500–1000 ppm indicate strong antifungal potential with implications for nanoparticle-based veterinary antifungal strategies.